Open House Pharmaceutical Discount Contracts for Fondaparinux, ATC B01AX05
AOK Bayern - Die Gesundheitskasse, MünchenTED 335740-2026
value not stated1 lot
Wed 3 May12:00 in Berlin
552days
Medical supplies contracts in Germany
1,507 open tenders
Email me new onesCountryTenderValueClosesDays left
Open House Pharmaceutical Discount Contracts for Abatacept, ATC L04AA24
AOK Bayern - Die Gesundheitskasse, MünchenTED 336029-2026
value not stated1 lot
Wed 3 May12:00 in Berlin
552days
Open house for pharmaceutical discount agreements for Botulinum toxin type A, finished medicinal product name Dysport(R)/Dysline(R), ATC M03AX21
AOK Bayern - Die Gesundheitskasse, MünchenTED 338689-2026
value not stated1 lot
Wed 3 May12:00 in Berlin
552days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Erythropoietin (Epoetin alfa and zeta only), ATC B03XA01, for the period 01.07.2026 - 30.06.2028
DAK-Gesundheit, HamburgTED 332949-2026
€11 lot, 2 years
Fri 5 May12:00 in Berlin
554days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Etravirin, ATC J05AG04, for the period 01.07.2026 - 30.06.2028
DAK-Gesundheit, HamburgTED 333477-2026
€11 lot, 2 years
Fri 5 May12:00 in Berlin
554days
Conclusion of a non-exclusive discount agreement pursuant to § 130a paragraph 8 SGB V for the active substance Piribedil, ATC N04BC08, for the period 01.07.2026 - 30.06.2028
DAK-Gesundheit, HamburgTED 332758-2026
€11 lot, 2 years
Fri 5 May12:00 in Berlin
554days
Conclusion of a non-exclusive discount agreement pursuant to § 130a paragraph 8 SGB V for the active substance Ixekizumab, ATC L04AC13, for the period 01.07.2026 - 30.06.2028
DAK-Gesundheit, HamburgTED 331788-2026
€11 lot, 2 years
Fri 5 May12:00 in Berlin
554days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Dornase alfa, ATC code R05CB13, for the period from 01.07.2026 to 30.06.2028
DAK-Gesundheit, HamburgTED 333976-2026
€11 lot, 2 years
Fri 5 May12:00 in Berlin
554days
Conclusion of a non-exclusive discount agreement pursuant to § 130a paragraph 8 SGB V for the active substance Propranolol (exclusively in liquid form for oral use), ATC C07AA05, for the period 01.07.2026 - 30.06.2028
DAK-Gesundheit, HamburgTED 332888-2026
€11 lot, 2 years
Fri 5 May12:00 in Berlin
554days
Pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) within open-house procedures
IKK classic, DresdenTED 426545-2026
value not stated32 lots
Fri 5 May23:59 in Berlin
554days
Open framework agreement on pharmaceutical discounts pursuant to § 130a para. 8 of the German Social Code Book V (SGB V), with possibility of accession at any time, so-called approval model 2026-07
Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 383076-2026
value not stated27 lots
Fri 5 May23:59 in Berlin
554days
Conclusion of non-exclusive discount agreements under § 130 a Abs. 8 SGB V as of 01.11.2026
GWQ ServicePlus AG, DüsseldorfTED 677151-2026
value not stated2 lots
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to Section 130 a, Paragraph 8 of Book V of the Social Code, effective from 15.12.2026
GWQ ServicePlus AG, DüsseldorfTED 731536-2026
value not stated2 lots
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 SGB V from 01.09.2026
GWQ ServicePlus AG, DüsseldorfTED 512375-2026
value not stated8 lots, 22 months
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 SGB V for the active substance from 01.10.2026
GWQ ServicePlus AG, DüsseldorfTED 599811-2026
value not stated3 lots, 20 months
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 SGB V for the active substances Bevacizumab and Rituximab
GWQ ServicePlus AG, DüsseldorfTED 362066-2026
value not stated2 lots, 2 years
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 SGB V from 01.08.2026
GWQ ServicePlus AG, DüsseldorfTED 431738-2026
value not stated2 lots, 22 months
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 of the German Social Code Book V (SGB V) as of 01.05.2026
GWQ ServicePlus AG, DüsseldorfTED 227181-2026
value not stated3 lots, 26 months
Wed 10 May10:00 in Berlin
559days
Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 of the German Social Code Book V (SGB V) as of 01.07.2026
GWQ ServicePlus AG, DüsseldorfTED 302376-2026
value not stated7 lots, 2 years
Wed 10 May10:00 in Berlin
559days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Ustekinumab (ATC-Code: L04AC05).
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 407882-2026
value not stated1 lot
Sat 27 May12:00 in Berlin
576days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.